Marc de Garidel
- Chairperson of the Board of Directors
Marc de Garidel – Chairman of the Board of Directors
Marc de Garidel joined Ipsen as Chairman and Chief Executive Officer in November 2010. He has been the Ipsen Chairman of the Board of Directors since July 2016.
Marc de Garidel is also Chief Executive Officer and Director of AZTherapies, Inc. since October 1st, 2020. He was previously, for 2 years and a half, Chief Executive Officer and Director of Corvidia Therapeutics, Inc. which was sold to Novo Nordisk in July 2020.
Marc de Garidel started his career with the group Eli Lilly and pursued at Amgen, from 1995 to 2010, with increasing responsibility positions in the US and Europe.
Marc de Garidel is Director of Claris Biotherapeutics since July 2020.
Previously, he was Director of several biotechnology companies, including Vice-Chairman of the Board of Directors of Vifor Pharma (Switzerland) between May 2017 and 2018 (formerly Galenica), of which he was member of the Board since 2015.
Marc de Garidel is a graduate from the French Engineering School ESTP and has an Executive MBA from Harvard Business School.